Schwalbach, Germany (PRWEB) July 19, 2011
BIT Analytical Instruments (http://www.BIT-companies.com) is approaching the completion of its new In Vitro Diagnostic (IVD) instrument development laboratory within its Germany facility. The new lab, will be used for functional testing of instruments and sub-modules during development. The company’s former lab space will be dedicated to electronic or optical testing as well as quality control.
In response to recent increases in IVD instrument development and manufacturing contracts, BIT invested nearly €1 Million in the construction of this new laboratory, as well as an extension of the assembly work area; both are expected to be ready in 2011.
For over 35 years BIT Companies (http://www.BIT-companies.com) have provided services in the field of contract development and manufacturing as well as after-sales service for customers in the fields of medical, diagnostics and biotechnology. As a part of the financially strong Messer Group, BIT Companies provide their systems solutions worldwide and in compliance with ISO 13485 and 9001 standards. As registered contract service providers to the FDA, BIT Companies meet the stringent regulations with regard to medical and medical technical products while simultaneously adhering to predefined design-to-cost and time-to-market targets.
BIT Companies include Source Scientific, LLC in Irvine, California, USA, BIT Analytical Instruments Ltd.in Ludlow, Massachusetts, USA, BIT Analytical Instruments GmbH in Schwalbach, Germany, BIT Technologies in Kunshan, China, BIT Japan Ltd. in Tokyo, and C2 Diagnostics in France.